Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
N-myc downstream-regulated gene 3
(
NDRG3
), an important member of the NDRG family, is involved in cell proliferation, differentiation, and other biological processes. The present study analyzed
NDRG3
expression in
hepatocellular carcinoma
(
HCC
) and explored the relationship between expression of
NDRG3
in
HCC
patients and their clinicopathological characteristics. We performed quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) analysis and immunohistochemistry (IHC) analyses on
HCC
tissues to elucidate
NDRG3
expression characteristics in
HCC
patients. Kaplan-Meier survival curve and Cox regression analyses were used to evaluate the prognoses of 102 patients with
HCC
. The results revealed that compared with non-tumor tissues,
HCC
tissues showed significantly higher
NDRG3
expression. In addition, our analyses showed that
NDRG3
expression was statistically associated with tumor size (
P
=0.048) and pathological grade (
P
=0.001). Survival analysis and Kaplan-Meier curves revealed that
NDRG3
expression is an independent prognostic indicator for disease-free survival (
P
=0.002) and overall survival (
P
=0.005) in
HCC
patients. The data indicate that
NDRG3
expression may be considered as a oncogenic biomarker and a novel predictor for
HCC
prognosis.
...
PMID:NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma. 3041 9